Alostine 20mg 14 tablets

Alostine 20mg is indicated for the symptomatic treatment of allergic rhinoconjunctivitis (seasonal and perennial) and urticaria in adults and adolescents from 12 years of age.

Active substance: Each tablet contains 20 mg of bilastine.

Dosage and method of administration:

Adults and adolescents (aged 12 years and over): 20 mg (1 tablet) once daily for the relief of symptoms of allergic rhinoconjunctivitis (ARS and APR) and urticaria. The tablet should be taken orally one hour before or two hours after eating or drinking fruit juices. The duration of treatment should be as short as possible and should not exceed 7 days. If symptoms persist for more than 3 days or worsen, patients should consult a doctor to minimize the risk of masking an underlying disease.

Contraindications:

Hypersensitivity to the active substance or to any of the excipients.

If in doubt or if symptoms persist, consult your doctor or pharmacist.

According to current legislation, non-prescription medicines in Portugal can only be delivered to the municipalities of Maia, Gondomar, Matosinhos, Porto, Santo Tirso, Trofa, Valongo and Vila do Conde. This limitation does not apply to shipments to other Member States of the European Union.